Impact on and adaptations by the national addictions management service in response to the COVID-19 pandemic

Affiliations

¹ National Addiction Management Service, Institute of Mental Health; Family Medicine and Primary Care, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
² National Addiction Management Service, Institute of Mental Health, Singapore.

Melvyn WeiBin Zhang et al. Singapore Med J. 2023 Jun.

. 2023 Jun;64(6):407-409.

doi: 10.11622/smedj.2021231.

¹ National Addiction Management Service, Institute of Mental Health; Family Medicine and Primary Care, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
² National Addiction Management Service, Institute of Mental Health, Singapore.

No abstract available

Conflict of interest statement

None

1. World Health Organization. Coronavirus disease (COVID-19) pandemic. [[Last accessed on 2020 Mar 26]]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 .
1. Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr. 2020;52:102066. - PMC - PubMed
1. Kar SK, Arafat SMY, Sharma P, Dixit A, Marthoenis M, Kabir R. COVID-19 pandemic and addiction: Current problems and future concerns. Asian J Psychiatr. 2020;51:102064. - PMC - PubMed
1. Jiang H, Su H, Zhang C, Liu X, Li R, Zhong N, et al. Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations. Eur Neuropsychopharmacol. 2020;35:136–7. - PMC - PubMed
1. Sun Y, Bao Y, Kosten T, Strang J, Shi J, Lu L. Editorial: Challenges to opioid use disorders during COVID-19. Am J Addict. 2020;29:174–5. - PMC - PubMed